Inside the battle for FDA approval of MDMA therapy
Briefly

"I absolutely agree that we need new and better treatments for PTSD," said Paul Holtzheimer, emphasizing the urgency for effective solutions and acknowledging the complexities involved in developing them.
"We need to ensure that we're relying on robust evidence and sound scientific methodology when considering the use of MDMA for therapy," highlightings stakeholders' responsibility for maintaining rigorous standards.
Read at Big Think
[
|
]